menu
    • menu

    Company profile for Algernon Pharmaceuticals

    NEW Drugs in Dev: 5
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Algernon Pharmaceuticals is a clinical stage drug development company focused on the areas of non–alcoholic steatohepatitis (NASH), chronic kidney disease (CKD), inflammatory bowel disease (IBD) and idiopathic pulmonary fibrosis (IPF). The Algernon drug development program was the brainchild of Dr. Mark Williams, the Company’s CSO, whose innovative approach to drug discovery was developed over many years as senior scientis...
    Algernon Pharmaceuticals is a clinical stage drug development company focused on the areas of non–alcoholic steatohepatitis (NASH), chronic kidney disease (CKD), inflammatory bowel disease (IBD) and idiopathic pulmonary fibrosis (IPF). The Algernon drug development program was the brainchild of Dr. Mark Williams, the Company’s CSO, whose innovative approach to drug discovery was developed over many years as senior scientist in the drug development industry. The company and its business model is highly capital efficient and strives to deliver maximum shareholder value.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Algernon PharmaceuticalsCanada Flag
    Country
    Country
    Canada
    Address
    Address
    Suite 915 – 700 West Pender Street Vancouver, BC
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://algernonpharmaceuticals.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Arvo

    Arvo

    Not Confirmed

    envelop Contact Supplier

    Arvo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Algernon Health Implements Name Change To 'Grey Matters Health
    Algernon Health Implements Name Change To 'Grey Matters Health

    15 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/15/3274860/0/en/Algernon-Health-Announces-Effective-Date-of-Previously-Announced-Name-Change-to-Grey-Matters-Health-Inc-and-its-10-1-Share-Consolidation.html

    GLOBENEWSWIRE
    15 Apr 2026
    Share Share
    Algernon Raises $858K in Private Placement, Closes Deal
    Algernon Raises $858K in Private Placement, Closes Deal

    31 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/31/3211900/0/en/Algernon-Announces-Additional-Increase-to-Private-Placement-Financing-to-858-000-and-Final-Closing-of-the-Financing.html

    GLOBENEWSWIRE
    31 Dec 2025
    Share Share
    Algernon Completes $750K Placement's Third Tranche
    Algernon Completes $750K Placement's Third Tranche

    23 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/23/3210126/0/en/Algernon-Announces-Increase-to-Private-Placement-Financing-to-750-000-and-Close-of-Third-Tranche.html

    GLOBENEWSWIRE
    23 Dec 2025
    Share Share
    Algernon Closes Second Tranche Of Private Placement Financing
    Algernon Closes Second Tranche Of Private Placement Financing

    28 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/29/3196492/0/en/Algernon-Closes-Second-Tranche-of-Private-Placement-Financing.html

    GLOBENEWSWIRE
    28 Nov 2025
    Share Share
    Algernon Completes Initial Phase Of New Private Placement Funding
    Algernon Completes Initial Phase Of New Private Placement Funding

    14 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/15/3188679/0/en/Algernon-Closes-First-Tranche-of-its-Recently-Announced-Private-Placement-Financing.html

    GLOBENEWSWIRE
    14 Nov 2025
    Share Share
    Algernon Pharmaceuticals Completes Name Change To Algernon Health
    Algernon Pharmaceuticals Completes Name Change To Algernon Health

    15 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/15/3166926/0/en/Algernon-Pharmaceuticals-Completes-Name-Change-to-Algernon-Health.html

    GLOBENEWSWIRE
    15 Oct 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search